Accession Number: | 0001209191-20-004123 |
Date: | 2020-01-15 |
Issuer: | AMICUS THERAPEUTICS, INC. (FOLD) |
Original Submission Date: |
CAMPBELL BRADLEY L
C/O AMICUS THERAPEUTICS, INC.
1 CEDAR BROOK DRIVE
CRANBURY, NJ 08512
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-01-15 | S | 5,064 | d | $10.35 | 370,520 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the exercise of stock options and subsequent sale of common stock were made pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | this price is the weighted average price for the transactions reported on this line. the prices for the transactions reported on this line range from $10.01 to $10.48 inclusive. the reporting person undertakes to provide, upon request, by the staff of the securities and exchange commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |